Malaty John, Malaty Irene A
Department of Community Health and Family Medicine, University of Florida, Gainesville, Florida, USA.
Department of Neurology, University of Florida, Gainesville, Florida, USA.
BMJ Case Rep. 2014 Oct 21;2014:bcr2014206022. doi: 10.1136/bcr-2014-206022.
A 46-year-old African-American man with a history of hypertension, end-stage kidney disease (on haemodialysis) and previous cocaine misuse presented to the emergency room with a sudden onset of severe headache and diaphoresis without other neurological or cardiovascular signs/symptoms. He checked his blood pressure at home and found it to be 230/130. It did not improve despite taking two serial doses of oral clonidine 0.3 mg. Evaluation with head CT and lumbar puncture demonstrated no acute intracranial process, such as subarachnoid haemorrhage. These symptoms started after he took Libido-Max, an over-the-counter supplement for erectile dysfunction. This supplement includes yohimbine, an α-2 antagonist, which counteracts the effects of oral clonidine, one of his routine antihypertensive medications. This led to rebound hypertension and made his hypertensive urgency resistant to oral clonidine. He was successfully treated with intravenous labetalol and his symptoms quickly resolved after lowering of his blood pressure.
一名46岁的非裔美国男性,有高血压、终末期肾病(正在接受血液透析)病史,既往有可卡因滥用史,因突发严重头痛和多汗就诊于急诊室,无其他神经或心血管体征/症状。他在家中测量血压,发现血压为230/130。尽管连续服用了两剂0.3毫克的口服可乐定,血压仍未改善。头颅CT和腰椎穿刺检查未发现急性颅内病变,如蛛网膜下腔出血。这些症状在他服用了一种治疗勃起功能障碍的非处方补充剂Libido-Max后开始出现。这种补充剂含有育亨宾,一种α-2拮抗剂,它抵消了他日常服用的降压药之一口服可乐定的作用。这导致了反弹性高血压,使他的高血压急症对口服可乐定耐药。他接受静脉注射拉贝洛尔治疗成功,血压降低后症状迅速缓解。